基本信息
浏览量:2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
My Research
KEYWORDS
Molecular virology, Host-virus interaction, HIV and SARS-CoV-2, Emerging mutations and structure-function relationships, Antiviral adaptive and innate immune responses, Immune correlates of protection/disease progression, Mechanisms of antiretroviral drug resistance, Superinfection and epidemiologically-linked infection, Emerging viruses and HIV recombinant forms, Viral diversity in West and Central Africa
Read Less
SUMMARY
The focus of my laboratory is on genetic and functional aspects of HIV-1 and SARS-CoV-2 infection and antiviral immune responses against these viruses. We are characterizing newly emerging viral strains and HIV recombinant forms, immune correlates of protection/disease progression, and mechanisms of antiretroviral drug resistance in HIV-1 Non-B clades.
We are studying global viral infections with a focus on cohorts in the West and Central African region, the epicenter of the AIDS epidemic, where the broadest variety of HIV strains exists, and where a high number of co-infections and increasing rates of SARS-CoV-2 infections occur. My colleagues and I are managing a cohort of HIV-1 infected individuals in Cameroon to investigate emerging viruses, HIV recombinant forms, and immune profiles induced by circulating HIV strains.
Our work involves extensive genotypic, phylogenetic, and immunologic studies. HIV-1 and SARS-CoV-2 whole-genome sequence analyses determine genotype-phenotype associations in conjunction with cross-sectional and longitudinal antibody immune response patterns. Furthermore, we study cases of superinfection and epidemiologically-linked infection. Through these studies, we aim to obtain a deeper understanding of viral-host interaction and antiviral immune responses, to eventually gain knowledge for vaccine design and the better management of viral infections. We are also engaged in unraveling mechanisms of drug-resistance mutations in HIV-1 non-B clades that are most abundant worldwide but understudied compared to clade B viruses, predominant in the USA and Europe.
Our group is committed to scientific discovery and supports the training of doctoral fellows and visiting students from the U.S. and abroad in virologic research, including African students, through participation in international research training programs.
KEYWORDS
Molecular virology, Host-virus interaction, HIV and SARS-CoV-2, Emerging mutations and structure-function relationships, Antiviral adaptive and innate immune responses, Immune correlates of protection/disease progression, Mechanisms of antiretroviral drug resistance, Superinfection and epidemiologically-linked infection, Emerging viruses and HIV recombinant forms, Viral diversity in West and Central Africa
Read Less
SUMMARY
The focus of my laboratory is on genetic and functional aspects of HIV-1 and SARS-CoV-2 infection and antiviral immune responses against these viruses. We are characterizing newly emerging viral strains and HIV recombinant forms, immune correlates of protection/disease progression, and mechanisms of antiretroviral drug resistance in HIV-1 Non-B clades.
We are studying global viral infections with a focus on cohorts in the West and Central African region, the epicenter of the AIDS epidemic, where the broadest variety of HIV strains exists, and where a high number of co-infections and increasing rates of SARS-CoV-2 infections occur. My colleagues and I are managing a cohort of HIV-1 infected individuals in Cameroon to investigate emerging viruses, HIV recombinant forms, and immune profiles induced by circulating HIV strains.
Our work involves extensive genotypic, phylogenetic, and immunologic studies. HIV-1 and SARS-CoV-2 whole-genome sequence analyses determine genotype-phenotype associations in conjunction with cross-sectional and longitudinal antibody immune response patterns. Furthermore, we study cases of superinfection and epidemiologically-linked infection. Through these studies, we aim to obtain a deeper understanding of viral-host interaction and antiviral immune responses, to eventually gain knowledge for vaccine design and the better management of viral infections. We are also engaged in unraveling mechanisms of drug-resistance mutations in HIV-1 non-B clades that are most abundant worldwide but understudied compared to clade B viruses, predominant in the USA and Europe.
Our group is committed to scientific discovery and supports the training of doctoral fellows and visiting students from the U.S. and abroad in virologic research, including African students, through participation in international research training programs.
研究兴趣
论文共 70 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Joaquín J Rodriguez Galvan,Maren de Vries, Shiraz Belblidia,Ashley Fisher,Rachel A Prescott,Keaton M Crosse, Walter F. Mangel,Ralf Duerr,Meike Dittmann
biorxiv(2024)
VIRUS EVOLUTIONno. 1 (2024): veae035-veae035
ERJ open researchno. 4 (2024): 00789-2023
Aaron L. Oom,Angelica C. Kottkamp, Kesi K. Wilson, Miilani Yonatan, Stephanie Rettig, Heekoung Allison Youn,Michael Tuen, Yusra Shah,Ashley L. DuMont,Marie I. Samanovic,Ralf Duerr,Mark J. Mulligan,
medrxiv(2024)
Nature Communicationsno. 1 (2023): 1-15
Lalitha Parameswaran, Anna Jaysing, Helen Ding,Marc Wilkenfeld, Ranekka Dean, Kesi K Wilson, Olivia Frank,Ralf Duerr,Mark J Mulligan
Journal of racial and ethnic health disparitiesno. 4 (2023): 2109-2119
Nature medicineno. 11 (2023): 2763-2774
Nature protocolsno. 12 (2023): 3821-3855
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn